These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 7836511

  • 1. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations.
    Gemzell-Danielsson K, Hamberg M.
    Hum Reprod; 1994 Sep; 9(9):1626-30. PubMed ID: 7836511
    [Abstract] [Full Text] [Related]

  • 2. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
    Nayak NR, Sengupta J, Ghosh D.
    Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
    [Abstract] [Full Text] [Related]

  • 3. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K, Swahn ML, Svalander P, Bygdeman M.
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [Abstract] [Full Text] [Related]

  • 4. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB, Salvatierra AM, Croxatto HD, Spitz IM.
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
    [Abstract] [Full Text] [Related]

  • 5. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
    Cameron ST, Critchley HO, Buckley CH, Kelly RW, Baird DT.
    Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC, Cartledge TP, Zellmer AW, Merino MJ, Axiotis C, Loriaux DL, Nieman LK.
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E.
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of mifepristone and antiestrogens on uterine PGF2 alpha and PGE2 concentrations in ovariectomized and pregnant rats.
    Li XJ, Yu H, Koide SS.
    Prostaglandins; 1997 Mar; 53(3):187-97. PubMed ID: 9206800
    [Abstract] [Full Text] [Related]

  • 16. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M.
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiprogestin drugs: research and clinical use in Sweden.
    Bygdeman M, Swahn ML.
    Law Med Health Care; 1992 Oct; 20(3):157-60. PubMed ID: 1434756
    [Abstract] [Full Text] [Related]

  • 20. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.